FDA Clears Once-Weekly Transdermal Patch for Alzheimer ' s FDA Clears Once-Weekly Transdermal Patch for Alzheimer ' s

The once-weekly patch delivers consistent doses of donepezil through the skin, bypassing the digestive system and potentially leading to fewer GI side effects, the manufacturer notes.FDA Approvals
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry News Alert Source Type: news